Zuvirab Vaccine

उत्पाद विवरण

1. Technical Specifications

2. Product Description

Zuvirab 0.5 ml Injection is a purified inactivated rabies vaccine used for both pre-exposure prophylaxis and post-exposure prophylaxis of rabies infection.
It stimulates the bodys immune system to produce antibodies against the rabies virus, thereby preventing the disease after suspected exposure (e.g., dog bites, scratches, or contact with potentially rabid animals).

3. Product Highlights

4. Therapeutic Uses

• Pre-exposure prophylaxis: For individuals at high risk (veterinarians, animal handlers, lab workers, travelers to endemic areas).

• Post-exposure prophylaxis: After suspected rabies exposure (animal bites, scratches, or contact with saliva).

• Administered along with Rabies Immunoglobulin (RIG) in category III exposures (severe bites).

5. Side Effects

Common:

• Pain, redness, or swelling at injection site

• Mild fever

• Headache, dizziness

• Fatigue, malaise

Rare but serious:

• Severe allergic reaction (anaphylaxis)

• Neurological reactions (extremely rare)

6. Precautions

• Should only be given under medical supervision.

• Must not be injected into the gluteal region (reduced effectiveness).

• Contraindicated in individuals with severe allergic reaction to previous rabies vaccination or any vaccine component.

• Pregnancy and breastfeeding: can be used when risk of rabies exposure is high (benefit outweighs risk).

• Immunocompromised patients may require additional doses or monitoring for antibody response.